glp-1 demand The trend: What the real-world data reveals GLP-1 is rewriting retail demand:
Description
Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system
A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to patients taking another diabetes medication, DPP-4 inhibitors
The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity
Link and QR code below.
Losing the Weight Loss Meds" by Drs
